drugset / Trial / NCT01785160
Investigation of Faldaprevir Effect on Pharmacokinetics of Raltegravir
Non-randomizedCrossoverOpen-labelTreatment
Summary
The primary objective of this trial is to investigate effect of faldaprevir on steady state pharmacokinetics of raltegravir. The assessment of safety and tolerability will be an additional objective of this trial.
Timeline
- Start
- 2013-02
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Faldaprevir | Small molecule | — | Oral |
| Subject | Raltegravir | Other / unclassified | — | Oral |
Indications
No indication recorded.